Does Rallies show 13F holders for IBB?

Yes. Rallies tracks hedge fund and 13F ownership data for IBB, including fund names, share counts, latest tracked quarter, and position changes when available.

Is IBB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IBB. It does not provide personalized investment advice.

IBB (Nasdaq Biotechnology) Stock Analysis - Hedge Fund Holdings

Nasdaq Biotechnology (IBB) is a publicly traded the market company. As of May 20, 2026, IBB trades at $167.69 with a market cap of $0 and a P/E ratio of 0.00. IBB moved +2.20% today. Year to date, IBB is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns IBB stock?

Hedge funds tracked by Rallies that own IBB include Mangrove Partners. The latest tracked quarter is Jun 30, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Nasdaq Biotechnology.

IBB Key Metrics

Key financial metrics for IBB
Metric	Value
Price	$167.69
Market Cap	$0
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$0.00
52-Week Low	$0.00
Volume	1.77M
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding IBB

Mangrove Partners holds 134.28K shares of IBB, changed +0.00% as of Jun 30, 2023.

Latest IBB News

IBB flat as biotech earnings setup and M&A optimism offset rate sensitivity — May 7, 2026
IBB holds near $170 as biotech balances rates, M&A buzz, and mixed catalysts — May 6, 2026
IBB holds steady as biotech digests big-pharma earnings and rate sensitivity — May 5, 2026
IBB holds steady as large-cap biotech earnings and rate outlook offset catalyst calendar — May 4, 2026
IBB flat as biotech digests mega-cap earnings and May FDA catalyst calendar — May 1, 2026

IBB Analyst Consensus

IBB analyst coverage data. Average price target: $0.00.

Common questions about IBB

Who owns IBB stock?: Hedge funds tracked by Rallies that own IBB include Mangrove Partners. The latest tracked quarter is Jun 30, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Nasdaq Biotechnology.
Does Rallies show 13F holders for IBB?: Yes. Rallies tracks hedge fund and 13F ownership data for IBB, including fund names, share counts, latest tracked quarter, and position changes when available.
Is IBB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IBB. It does not provide personalized investment advice.